These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33637303)

  • 21. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
    Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
    Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
    Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
    Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dopaminergic system in medial prefrontal cortex on ketamine-induced amnesia in passive avoidance task in mice.
    Farahmandfar M; Bakhtazad A; Akbarabadi A; Zarrindast MR
    Eur J Pharmacol; 2016 Jun; 781():45-52. PubMed ID: 27041647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
    Cavalleri L; Merlo Pich E; Millan MJ; Chiamulera C; Kunath T; Spano PF; Collo G
    Mol Psychiatry; 2018 Apr; 23(4):812-823. PubMed ID: 29158584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.
    Can A; Zanos P; Moaddel R; Kang HJ; Dossou KS; Wainer IW; Cheer JF; Frost DO; Huang XP; Gould TD
    J Pharmacol Exp Ther; 2016 Oct; 359(1):159-70. PubMed ID: 27469513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway.
    Kamiyama H; Matsumoto M; Otani S; Kimura SI; Shimamura KI; Ishikawa S; Yanagawa Y; Togashi H
    Neuroscience; 2011 Mar; 177():159-69. PubMed ID: 21163337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketamine ameliorates activity-based anorexia of adolescent female mice through changes in GluN2B-containing NMDA receptors at postsynaptic cytoplasmic locations of pyramidal neurons and interneurons of medial prefrontal cortex.
    Li J; Temizer R; Chen YW; Aoki C
    Brain Struct Funct; 2024 Mar; 229(2):323-348. PubMed ID: 38170266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
    Liu RJ; Lee FS; Li XY; Bambico F; Duman RS; Aghajanian GK
    Biol Psychiatry; 2012 Jun; 71(11):996-1005. PubMed ID: 22036038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.
    Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS
    Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
    Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
    Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemogenetic Suppression of Medial Prefrontal-Dorsal Hippocampal Interactions Prevents Estrogenic Enhancement of Memory Consolidation in Female Mice.
    Tuscher JJ; Taxier LR; Schalk JC; Haertel JM; Frick KM
    eNeuro; 2019; 6(2):. PubMed ID: 31016230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.
    Ago Y; Tanabe W; Higuchi M; Tsukada S; Tanaka T; Yamaguchi T; Igarashi H; Yokoyama R; Seiriki K; Kasai A; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):665-674. PubMed ID: 31325908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-Ketamine Reverses Hippocampal Dendritic Spine Deficits in Flinders Sensitive Line Rats Within 1 h of Administration.
    Treccani G; Ardalan M; Chen F; Musazzi L; Popoli M; Wegener G; Nyengaard JR; Müller HK
    Mol Neurobiol; 2019 Nov; 56(11):7368-7379. PubMed ID: 31037646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine pathways mediating affective state transitions after sleep loss.
    Wu M; Zhang X; Feng S; Freda SN; Kumari P; Dumrongprechachan V; Kozorovitskiy Y
    Neuron; 2024 Jan; 112(1):141-154.e8. PubMed ID: 37922904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual experience enhances cognitive flexibility and dendritic spine density in the medial prefrontal cortex.
    Glasper ER; LaMarca EA; Bocarsly ME; Fasolino M; Opendak M; Gould E
    Neurobiol Learn Mem; 2015 Nov; 125():73-9. PubMed ID: 26188276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.
    Moghaddam B; Adams B; Verma A; Daly D
    J Neurosci; 1997 Apr; 17(8):2921-7. PubMed ID: 9092613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental Stage-dependent persistent impact of propofol anesthesia on dendritic spines in the rat medial prefrontal cortex.
    Briner A; Nikonenko I; De Roo M; Dayer A; Muller D; Vutskits L
    Anesthesiology; 2011 Aug; 115(2):282-93. PubMed ID: 21701379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex.
    Temizer R; Chen YW; Aoki C
    Synapse; 2023 Jan; 77(1):e22253. PubMed ID: 36121749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.